Bruker Daltonics
This article was originally published in The Gray Sheet
Executive Summary
Firm goes public Aug. 4 via initial offering of 8 mil. shares at $13 each under the Nasdaq symbol "BDAL." The Billerica, Massachusetts maker of mass spectrometry life science tools plans to use gross proceeds of $104 mil. for the expansion of sales and marketing capabilities, R&D, debt repayment, working capital, potential acquisitions and other general corporate purposes. UBS Warburg LLC is the lead manager for the offering, with CIBC World Markets and Thomas Weisel Partners LLC co-managing. The underwriters hold an over-allotment option of 1.2 mil. additional shares